Pharmaceutical stock price index showing four-month consecutive rallies

Published: 2003-05-13 07:00:00

Updated: 2003-05-13 07:00:00

Influenced by the jitters over severe acute respiratory syndrome (SARS), the pharmaceutical stock price index on April showed an average increase of 14.9 percent, led by SARS-related shares, over the main bourse index Kopsi posting a modest increase of 2.14 percent, according to a recent report r...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK